Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Topical JAK inhibitors may help treat some skin conditions but need more research.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Citrullus colocynthis has pain-relieving, anti-inflammatory, antidiabetic, and hair growth benefits, but can cause side effects like colic and diarrhea.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Skin reactions to antidepressants are common but usually not serious and can be treated.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.